Capillary electrophoresis analysis of hydrolysis, isomerization and enantiomerization of aspartyl model tripeptides in acidic and alkaline solution

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 1, 2007, Pages 49-56

  De Boni, Silvia ^a   Scriba, Gerhard K E ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Aspartyl peptide; Capillary electrophoresis; Enantiomerization; Isomerization; Peptide degradation

Indexed keywords

ACID; ALKALI; AMINO ACID; BUFFER; CARBOXYMETHYL BETA CYCLODEXTRIN; DIPEPTIDE; ELECTROLYTE; GLYCYLASPARTYLPHENYLALANINAMIDE; PHENYLALANYLASPARTYLGLYCINAMIDE; SODIUM DIHYDROGEN PHOSPHATE; TRIPEPTIDE DERIVATIVE;

ACIDITY; ALKALINITY; ARTICLE; CAPILLARY ELECTROPHORESIS; CARBOXY TERMINAL SEQUENCE; CHEMICAL REACTION; DEAMINATION; DRUG DEGRADATION; DRUG STRUCTURE; ENANTIOMERIZATION; HYDROLYSIS; ISOMERIZATION; LIGHT ABSORPTION; PRIORITY JOURNAL; SEPARATION TECHNIQUE; STEREOSPECIFICITY; ULTRAVIOLET RADIATION; VALIDATION STUDY;

ACIDS; ALKALIES; AMINO ACIDS; ASPARTIC ACID; CROSS-LINKING REAGENTS; CYCLODEXTRINS; ELECTROPHORESIS, CAPILLARY; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; ISOMERISM; OLIGOPEPTIDES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

EID: 33845207781     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.06.012     Document Type: Article

References (28)

1. Walsh G. Nat. Biotechnol. 21 (2003) 865-870
2. Walsh G. Eur. J. Pharm. Biopharm. 55 (2003) 3-10
3. Manning M.C., Patel K., and Borchardt R.T. Pharm. Res. 6 (1989) 903-918
4. Aswad D.W. Deamidation and Isoaspartate Formation in Peptides and Proteins (1995), CRC Press, Boca Raton
5. Radkiewicz J.L., Zipse H., Clarke S., and Houk K.N. J. Am. Chem. Soc. 118 (1996) 9148-9155
6. Geiger T., and Clarke S. J. Biol. Chem. 262 (1987) 785-794
7. Min Wong C., Molnar T.E., Windisch V.L., and McKean R.E. Int. J. Pharm. 190 (1999) 1-11
8. Hekman C.M., DeMond W.S., Kelley P.J., Mauch S.F., and Williams J.D. J. Pharm. Biomed. Anal. 20 (1999) 763-772
9. Ritz-Timme S., and Collins M.J. Ageing Res. Rev. 1 (2002) 43-59
10. Clarke S., Stephenson R.C., and Lowenson J.D. In: Ahern T.J., and Manning M.C. (Eds). Stability of Protein Pharmaceuticals. Part A. Chemical and Physical Pathways of Protein Degradation (1992), Plenum Press, New York 1-29
11. Oliyai C., and Borchardt R.T. Pharm. Res. 11 (1994) 751-758
12. Radkiewicz J.L., Zipse H., Clarke S., and Houk K.N. J. Am. Chem. Soc. 123 (2001) 3499-3506
13. Capasso S., Kirby A.J., Salvadori S., Sica F., and Zagari A. J. Chem. Soc., Perkin Trans. 2 (1995) 437-442
14. Sadakane Y., Yamazaki T., Nakagomi K., Akizawa T., Fujii N., Tanimura T., Kaneda M., and Hatanaka Y. J. Pharm. Biomed. Anal. 30 (2003) 1825-1833
15. Kaneda M., Nakagomi K., Sadakane Y., Yamazaki T., Tanimura T., Akizawa T., Fujii N., and Hatanaka Y. J. Liq. Chromatogr. Rel. Technol. 25 (2002) 2445-2454
16. Weiss M., Manneberg M., Juranville J.-F., Lahm H.-W., and Fountoulakis M. J. Chromatogr. A 795 (1998) 263-275
17. Smith D.G., Stein W.H., and Moore S. J. Biol. Chem. 238 (1963) 227-234
18. De Boni S., Neusüß C., Pelzing M., and Scriba G.K.E. Electrophoresis 24 (2003) 874-882
19. De Boni S., Oberthür C., Hamburger M., and Scriba G.K.E. J. Chromatogr. A 1022 (2004) 95-102
20. Kasicka V. Electrophoresis 27 (2006) 142-175
21. Scriba G.K.E. Electrophoresis 27 (2006) 222-230
22. Perez P., Simo C., Neususs C., Pelzing M., San Roman J., Cifuentes A., and Gallardo A. Biomacromolecules 7 (2006) 720-727
23. Bodanszky M., and Bodanszky A. The Practice of Peptide Synthesis. second ed. (1994), Springer, Berlin
24. Chan W.C., and White P.D. Fmoc Solid Phase Peptide Synthesis (2000), Oxford University Press, New York
25. Schön I., and Kisfaludy L. Int. J. Peptide Protein Res. 14 (1979) 485-494
26. Mikulcik P., Riede J., and Schmidbaur H. Chem. Ber. 124 (1991) 2743-2746
27. Cloos P.A.C., and Fledelius C. Biochem. J. 345 (2000) 473-480
28. Aylin F., Konuklar S., and Aviyente V. Org. Biomol. Chem. 1 (2003) 2290-2297